Jean-Michel Vernier

Jean-Michel Vernier

Corporate Officer/Principal bij Ignyta Operating, Inc.

63 jaar
Health Technology
Consumer Services

Profiel

Jean-Michel Vernier is the founder of Selexagen Therapeutics, Inc. He currently holds the position of Vice President-Medicinal Chemistry at Ignyta Operating, Inc. Vernier has previously worked as Associate Director-Chemistry at Bausch Health Americas, Inc., Senior Research Scientist at Sibia Neurosciences, Inc., Vice President-Discovery Chemistry at Ardea Biosciences, Inc., and Senior Chemistry Investigator at Merck Research Laboratories Massachusetts LLC.
He has also held the position of Head-Medicinal Chemistry at Aravive Biologics, Inc. from 2012 to 2013 and Vice President-Chemistry Department at Ignyta, Inc. from 2013 to 2018.
Vernier holds a doctorate degree from the University of Strasbourg.

Actieve functies van Jean-Michel Vernier

BedrijvenFunctieBegin
Corporate Officer/Principal 01-06-2013
Alle actieve functies van Jean-Michel Vernier

Eerdere bekende functies van Jean-Michel Vernier

BedrijvenFunctieEinde
IGNYTA INC Corporate Officer/Principal 01-12-2018
Corporate Officer/Principal 01-04-2013
Sibia Neurosciences, Inc. Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Ervaring van Jean-Michel Vernier in detail bekijken

Opleiding van Jean-Michel Vernier

University of Strasbourg Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Jean-Michel Vernier in detail bekijken

Connecties

28

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit8

Health Technology

Health Technology

Health Technology

Selexagen Therapeutics, Inc.

Health Technology

Health Technology

Sibia Neurosciences, Inc.

Health Technology

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Jean-Michel Vernier